Journal Detail Information

1

Cite

Share

A case report of ovarian sex cord-stromal tumor, unclassified type.

Ji Young PARK ; Su Young LIM ; Dong Ook LEE ; Sung Won LEE ; Yong CHO ; Eu Sun RO ; Young Hee CHOI

Korean Journal of Gynecologic Oncology.2006;17(3):252-256.

Unclassified type occupies about 5 to 10 percent of all ovarian sex cord stromal tumors. Diagnosis is very difficult and subjective because tumors show insufficient differentiation to ovarian or testicular line or display insufficient findings to diagnose as a gynandroblastoma in spite of divergent differentiation. To our knowledge sixty-two cases have been reported in the pathology literatures as yet. The behavior of this group of tumors has not been adequately studied but is similar to granulose cell tumors or Sertoli-Leydig cell tumors. We present a case of unclassified sex cord-stromal tumor which has been experienced in our hospital with brief review of the literature.
Diagnosis ; Female ; Ovary ; Pathology ; Sertoli-Leydig Cell Tumor ; Sex Cord-Gonadal Stromal Tumors*

2

Cite

Share

A case of uterine tumor resembling ovarian sex-cord tumor.

Sun Young KWON ; Chi Heum CHO

Korean Journal of Gynecologic Oncology.2006;17(3):246-251.

Uterine tumor resembling ovarian sex cord tumors (UTROSCTs) are uncommon neoplasms that histologically resemble ovarian sex cord tumor. Over 50 cases have been reported up to recently. Clement and Scully reported 14 cases of UTROSCT, which they devided into two groups by clinicopathological features. Group I tumors are endometrial stromal sarcomas with partially sex-cord like elements (less than 40% of total tumor volume). On the other hand, group II tumors are mostly or entirely composed of sex-cord like elements. We have experienced a very rare case of type II UTROSCT at the uterine fundus in a 52-year-old woman and report it with a brief review of the literatures.
Female ; Hand ; Humans ; Middle Aged ; Sarcoma, Endometrial Stromal

3

Cite

Share

Ovarian carcinoma initially presenting as enlargement of axillary lymph node.

Chun June LEE ; Chang Wan JOEN

Korean Journal of Gynecologic Oncology.2006;17(3):241-245.

Ovarian carcinoma is usually asymptomatic in early stage and over 70% of it initially diagnose advanced stage due to diffuse intraabdominal disease. Presenting symptoms and signs often relate to the degree of intraabdominal spread. The most common presenting symptoms and sign include abdominal pain, distension and palpable pelvic mass. The enlarged finding of isolated, distant lymph node without intraabdominal symptom and sign is vary rare. We experienced a patient who initially diagnosed enlarged axillary lymph node from ovarian carcinoma. We report this case with a brief review of literature.
Abdominal Pain ; Humans ; Lymph Nodes*

4

Cite

Share

Comparison of cyclooxygenase-2 and p53 expression in normal endometrium, endometrial hyperplasia and endometrial cancer.

Sang Wook YOO ; Ok Kyong KIM ; Jae Yun SONG ; Soon Cheol HONG ; Nak Woo LEE ; Kyu Wan LEE

Korean Journal of Gynecologic Oncology.2006;17(3):234-240.

OBJECTIVE: The purpose of this study is to compare the expression rate of cyclooxygenase-2 (COX-2), p53 in endometrial hyperplasia, endometrial cancer and normal endometrium and to correlate COX-2 with the clinicopathological factors and p53 in endometrial cancer. METHODS: Immunohistochemical stain of COX-2, p53 was performed on samples from a series of 19 cases of normal proliferative endometrium, 20 cases of complex endometrial hyperplasia and 19 cases of endometrial cancer. And then we analyzed the expression of COX-2 correlated the findings with clinicopathological factors and p53. Expression of COX-2 was scored according to the proportion of positive-staining cells: negative, no staining; 1+, <10%; 2+, 10-50%; 3+, >50. For p53 overexpression, when there were at least 10% of tumor cells stained, it was considered as positive. RESULTS: Overexpression of COX-2 (> or =2+) was seen in 5 (26.3%) of the endometrial cancers, 6 (30%) of the complex endometrial hyperplasia, and 4 (21.1%) of the normal endometria. The expression rates of COX-2 in endometrial cancer, hyperplasia and normal endometrium were not different statistically significant (p=0.93). COX-2 was not correlated with clinicopathological factors but correlated with p53 significantly (p=0.021). CONCLUSION: In this study, the immunohistochemical analysis showed no difference statistically in COX-2 expression between endometrial cancer and hyperplasia compared to normal endometria. COX-2 was significantly correlated with p53. This finding may represent that tumor suppressor p53 upregulates COX-2 expression.
Cyclooxygenase 2* ; Endometrial Hyperplasia* ; Endometrial Neoplasms* ; Endometrium* ; Female ; Hyperplasia

5

Cite

Share

The effect of lymphadenectomy on the survival rate of clinical stage I endometrial cancer.

Mee Won SEO ; Hee Young LEE ; Dae Yeon KIM ; Dae Sik SUH ; Jong Hyeok KIM ; Yong Man KIM ; Young Tak KIM ; Joo Hyun NAM

Korean Journal of Gynecologic Oncology.2006;17(3):227-233.

OBJECTIVE: To evaluation of the effect of pelvic or paraaortic lymphadenectomy on survival rates in the management of clinical stage I endometrial cancer METHODS: A retrospective analysis was performed on a total 303 clinical stage I endometrial cancer patients from 1989 to 2004 at Asan Medical Center. Two hundred-sixty-three (86.8%) underwent a total hysterectomy and bilateral salpingo-oophorectomy with pelvic or paraaortic lymphadenectomy, while forty (13.2%) underwent a total hysterectomy and bilateral salpingo-oophorectomy only. Characteristics of patients and 5-year survival rate of each patients group were analyzed. RESULTS: Seventeen (6.5%) showed lymph node metastases and overall 5-year survival rate of clinical stage I endometrial cancer was 96.9%. The 5-year and 10-year survival rate of a group with lymphadenectomy were 96.4% and 86.6%, and those of a group without lymphadenectomy were 100% and 75.2%, respectively (p=0.48). The 5-year survival rate of a group with positive lymph nodes was 73.3%, that of a group with negative lymph nodes was 97.7% (p<0.05). CONCLUSION: The complete staging operation including lymphadenectomy did not improve the survival rates in a group with lymphadenectomy significantly. But the debates regarding the necessarity of lymphadenectomy in clinical stage I endometrial cancer still remains and a large randomized prospective study is needed.
Chungcheongnam-do ; Endometrial Neoplasms* ; Female ; Humans ; Hysterectomy ; Lymph Node Excision* ; Lymph Nodes ; Neoplasm Metastasis ; Retrospective Studies ; Survival Rate*

6

Cite

Share

Efficacy of loop conization with right-angled triangular shaped excisor in patients with cervical intraepithelial neoplasia 3.

Il Jung CHOI ; Bong Gyu KWAK ; Moon Seok CHA

Korean Journal of Gynecologic Oncology.2006;17(3):222-226.

OBJECTIVE: To evaluate the therapeutic value of conization using right-angled triangular shape loop cone biopsy excisor in patients with CIN 3 who want preserve the uterus. METHODS: A retrospective review of 64 patients was performed who underwent therapeutic conization for CIN 3 by using right-angled triangular shape loop cone biopsy excisor from January 2000 to August 2005. RESULTS: The mean duration of 64 follow-up patients who had conization for therapeutic purpose was 21.5 months (range 10-68). Their mean age was 41.1 years old and mean parity was 1.7. Two of 64 patients had CIN 3 on exocervix margin. During the followed up period, only one person (1/64) had relapse of CIN 3, hence, a simple hysterectomy was done. CONCLUSION: Right-angled triangular shape loop cone biopsy excisor is more effective than U-shaped loop with low rate of margin positive and recurrent rate in conservative treatment in CIN 3 patients who want to preserve uterus or fertility.
Biopsy ; Cervical Intraepithelial Neoplasia* ; Conization* ; Female ; Fertility ; Follow-Up Studies ; Humans ; Hysterectomy ; Parity ; Recurrence ; Retrospective Studies ; Uterus

7

Cite

Share

Outcome of cervical cancer in extremely elderly patients receiving radiation therapy.

Hae Rim SHIN ; Sang Heon KIM ; Beob Jong KIM ; Moon Hong KIM ; Seok Cheol CHOI ; Sang Young RYU ; Eui Don LEE ; Kyung Hee LEE

Korean Journal of Gynecologic Oncology.2006;17(3):218-221.

OBJECTIVE: The aim of this study was to evaluate the tolerance and outcome of elderly cervical cancer patients who were treated with radiation therapy retrospectively. METHODS: Fourteen patients over 80 years with pathologically proven stage I-IV cervical cancer who were treated with definitive RT between 1993 and 2003 were analyzed. We investigated response rates, recurrence rates, complications, progression free intervals, and current status of subjects. RESULTS: The age of the 14 patients ranged from 80 to 88 (median age: 81). The distribution of clinical stage by FIGO classification were > or =stage IIB (78.6%). The most common histologic type was squamous cell carcinoma. Nine patients (64.3%) underwent definitive radiation therapy. Among the 9 patients who had undergone radiotherapy, 7 patients (77.8%) showed complete response. One patient underwent surgical intervention followed by chemotherapy due to progression of disease despite radiotherapy. Two patients experienced radiation cystitis and 1 patient suffered from radiation colitis, however, other patients did not manifestate significant complications. One patient who underwent palliative chemotherapy due to persistent disease experienced mild marrow suppression and neurologic symptoms temporarily. CONCLUSION: The elderly patients over 80 years with good performance status may tolerate definitive pelvic radiation administered according to conventional fractionation schedules to control cervical cancer. Definitive radiation therapy with or without concurrent chemotherapy should not be excluded as a treatment option even for patients older than 80 years.
Aged* ; Appointments and Schedules ; Bone Marrow ; Carcinoma, Squamous Cell ; Classification ; Colitis ; Cystitis ; Drug Therapy ; Humans ; Neurologic Manifestations ; Radiotherapy ; Recurrence ; Retrospective Studies ; Uterine Cervical Neoplasms*

8

Cite

Share

Comparison of prognosis of FIGO stage IB 1 adenocarcinoma and squamous cell carcinoma who were treated primarily by surgery.

Jae Yun LIM ; Myung Seop SONG ; Jae Sik HONG ; Seok Ju SEONG ; Tae Jin KIM ; Kyung Taek LIM ; Jae Uk SHIM ; Chong Taik PARK ; Ki Heon LEE

Korean Journal of Gynecologic Oncology.2006;17(3):213-217.

OBJECTIVE: The objective of this study was to compare clinical and pathologic variables and prognosis of FIGO stage IB 1 adenocarcinoma and squamous cell carcinoma of uterine cervix who were treated primarily by surgery. METHODS: From May 1982 to October 2000, 2,209 patients with invasive cancer of the uterine cervix were diagnosed and treated at Cheil Hospital. A retrospective review was performed of 533 patients with stage IB1 squamous cell carcinoma (group A) and 84 with adenocarcinoma (group B) of cervix who treated primarily by type 3 hysterectomy and pelvic and paraaortic lymphadenectomy. RESULTS: Age, endometrial extension, lymph node metastasis and postoperative adjuvant therapy were not different between two group. There were more the lymphovascular space invasion in group A (136 patients, 25.5%) than group B (9 patients, 10.7%) (p<0.0046). 5 year survival were 95.0% vs 93.8% for group A and group B (p=0.75). Using univariate analysis, pelvic node metastasis, paraaortic metastasis, postoperative adjuvant therapy were significant for survival. Multivariate analysis of 5 year survival revealed independent prognostic factor as postoperative adjuvant therapy. CONCLUSION: Prognosis of FIGO stage IB1 cervical cancer patients who were treated by primarily by type 3 hysterectomy and pelvic and paraaortic lymphadenectomy between adenocarcinoma and squamous cell carcinoma was found to be same.
Adenocarcinoma* ; Carcinoma, Squamous Cell* ; Cervix Uteri ; Female ; Humans ; Hysterectomy ; Lymph Node Excision ; Lymph Nodes ; Multivariate Analysis ; Neoplasm Metastasis ; Prognosis* ; Retrospective Studies ; Survival Rate ; Uterine Cervical Neoplasms

9

Cite

Share

Profile of vaginal human papillomavirus infection in hysterectomized women.

Ok Kyong KIM ; Sung Kun KIM ; Jae Yun SONG ; Soon Cheol HONG ; Nak Woo LEE ; Kyu Wan LEE

Korean Journal of Gynecologic Oncology.2006;17(3):205-212.

OBJECTIVE: To examine HPV infection of vagina in the absence of cervical tissue and, thus, to determine whether the cervix, and especially the cervical transformation zone, is required for HPV infection. METHODS: We analyzed the result of pap smears that were interpreted with the Bethesda system, and the result of HPV tests of 376 hysterectomized women and 605 non-hysterectomized women who had visited in Korea medical health care center from August 2004 to December 2005. HPV test was performed with the commercially available Hybrid Capture II assay. We estimated the prevalence of vaginal HPV infection in hysterectomised and non-hysterectomized women. The variables selected for analysis were age, time of hysterectomy, self reported reasons for hysterectomy, parity and so on. RESULTS: Prevalence of vaginal HPV infection in hysterectomized women was 12.5% and non-hysterectomized women was 11.7%, showed no difference (p=0.72). The mean viral load of hysterectomized group was 79.1 and that of non-hysterctomized group was 173.9, which show no statistical difference between group (p=0.28). The cause of operation, age, duration since the operation, age group-specific duration since operation showed no difference in prevalence of HPV infection. Menopause state also did not show difference in HPV infection (p=0.67). CONCLUSION: On the basis of the present study's data, we suggest that the cervix, particularly the cervical transformation zone, may not be needed for HPV infection in vagina.
Cervix Uteri ; Delivery of Health Care ; Female ; Humans* ; Hysterectomy ; Korea ; Menopause ; Papillomavirus Infections* ; Parity ; Prevalence ; Self Report ; Vagina ; Viral Load

10

Cite

Share

Immunohistochemical analysis of pelvic lymph node micrometastases in cervical cancer patients with histologically negative nodes.

Jeong Sig KIM ; Kye Hyun NAM ; Hae Hyeog LEE ; Hee Kyung KIM ; Dong Han BAE

Korean Journal of Gynecologic Oncology.2006;17(3):200-204.

OBJECTIVE: The purpose of this study was to identify, by immunohistochemistry, possible micrometastasis in the pelvic lymph nodes previously considered free by conventional histopathological examination, and to assess their influence on the survival of patients with cervical cancer. METHODS: This retrospective study included patients (n=51) operated on between February 2001 and May 2004 for cervical cancer without histopathologic lymph node involvement. Lymph nodes (n=282) from 51 patients with histologically node-negative cervical cancer were evaluated for micrometastasis. These were submitted to immunohistochemical study using AE1/AE3 anti-cytokeratin monoclonal antibodies to identify neoplastic epithelial cells. RESULTS: The mean age of the patients was 45.3 years (range, 27-72). Lymph node micrometastases were immunohistochemically detected in 3 of the 51 patients (5.9%), comprising 3 of 282 (1.1%) pelvic lymph nodes examined. One patient (Ib2) had adenocarcinoma and others (Ib1,Ib2), squamous cell carcinoma. All of them had negative lymph-vascular space invasion. In three patients, there were recurrences (66.7%, 2/3), and one patient (Ib1) died from the pelvic recurrence. CONCLUSION: We recommend an immunohistochemical examination for lymph node micrometastases in cervical cancer patients with histologically negative nodes. This immunohistochemical method can be employed successfully in the detection of neoplastic cells in lymph nodes previously considered free. Micrometastasis could provide important information for further treatment strategies and follow up. Its clinical significance in cervical cancer warrants further study.
Adenocarcinoma ; Antibodies, Monoclonal ; Carcinoma, Squamous Cell ; Epithelial Cells ; Follow-Up Studies ; Humans ; Immunohistochemistry ; Keratins ; Lymph Nodes* ; Neoplasm Micrometastasis* ; Recurrence ; Retrospective Studies ; Uterine Cervical Neoplasms*

DISPLAY OPTIONS

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share